Single‐Shot Intrathecal Bupivacaine With Fentanyl vs. Dexmedetomidine for Labor Analgesia: A Randomized Controlled Trial
Anesthesiology Research and Practice · 2026-01 · 2026 (1)
DOI: 10.1155/anrp/6685169 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Anesthesiology Research and Practice, online erschienen am 29.04.2026. Verfasst von Ayman Mohamady Eldemrdash und 4 weiteren Autor:innen. Beteiligte Einrichtung: Anesthesiology, Surgical Intensive Care and Pain Medicine Department, Faculty of Medicine, Aswan University, Aswan, Egypt, aswu.edu.eg. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Labor pain is one of the most intense physiological pains experienced by women. Single‐shot spinal analgesia (SSSA) offers rapid and reliable labor pain relief. Combining bupivacaine with adjuvants like fentanyl or dexmedetomidine has been proposed to enhance analgesic efficacy and maternal comfort.
Methods
In this randomized, double‐blind clinical trial, 90 full‐term parturients in active labor were randomly allocated into three equal groups: Group B: 2.5 mg intrathecal bupivacaine with 0.5 mL of saline; Group BF: 2.5 mg bupivacaine with 25 μg fentanyl; Group BD: 2.5 mg bupivacaine with 5 μg dexmedetomidine. We compared the duration and onset of analgesia, pain scores on the visual analog scale (VAS), maternal satisfaction using the short assessment of patient satisfaction (SAPS), adverse effects, and neonatal outcomes.
Results
Group BD demonstrated the fastest onset of analgesia (2.1 ± 0.7 min) and the longest duration (124.2 ± 15.4 min), compared to Group BF (3.6 ± 0.9 min; 106.2 ± 18.9 min) and Group B (4.2 ± 1.0 min; 80.4 ± 14.6 min) ( p < 0.001). The pattern of pain reduction over time varied across treatments; Group BD showed the most rapid and sustained decrease in pain intensity, while Group B exhibited the slowest decline. A significant time × group interaction ( p < 0.001, partial η 2 = 0.67, i.e., large effect size) was observed. Maternal satisfaction scores were significantly higher in Group BD (26.63 ± 2.03) than in BF (22.00 ± 3.29) or B (15.27 ± 3.68) ( p < 0.01). The incidence of itching and nausea was higher in the BF group, and mild bradycardia was found in the BD group. Apgar scores at 1 and 5 min were similar in all groups.
Conclusion
Dexmedetomidine added to intrathecal bupivacaine produced good labor analgesia with high maternal satisfaction, with low side effects, and could be used as a better substitute for fentanyl. Trial Registration: ClinicalTrials.gov: NCT06823349
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Anesthesiology, Surgical Intensive Care and Pain Medicine Department, Faculty of Medicine, Aswan University, Aswan, Egypt, aswu.edu.eg.
ORCID-Profile: Ayman Mohamady Eldemrdash
Zitieren
APA
Eldemrdash, A. M., Elsawy, T. T. D., Zaher, Z. Z., Younan, J. S., & Ragheb, A. M. R. (2026). Single‐Shot Intrathecal Bupivacaine With Fentanyl vs. Dexmedetomidine for Labor Analgesia: A Randomized Controlled Trial. Anesthesiology Research and Practice, 2026(1). https://doi.org/10.1155/anrp/6685169
Vancouver
Eldemrdash AM, Elsawy TTD, Zaher ZZ, Younan JS, Ragheb AMR. Single‐Shot Intrathecal Bupivacaine With Fentanyl vs. Dexmedetomidine for Labor Analgesia: A Randomized Controlled Trial. Anesthesiology Research and Practice. 2026;2026(1). doi:10.1155/anrp/6685169
BibTeX
@article{Eldemrdash2026,
author = {Eldemrdash, Ayman Mohamady and Elsawy, Taha Tairy Dardeer and Zaher, Zaher Zaki and Younan, Jehan Sadek and Ragheb, Ahmed Mohammed Reda},
title = {Single‐Shot Intrathecal Bupivacaine With Fentanyl vs. Dexmedetomidine for Labor Analgesia: A Randomized Controlled Trial},
journal = {Anesthesiology Research and Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/anrp/6685169}
}
EUVIMED